Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T14:10:58.809Z.
Calculation as of: 2026-10-06T14:10:58.809Z.
Quote observation: 2026-10-06T14:10:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fa76e0b4cf372acfd55719bf770982f56833f7348901d63cf8ce2fa77c35bda7
EARNINGS YIELD
N/A
EARNINGS YIELD AVG TTM
N/A
EARNINGS YIELD AVG 3Y
N/A
EARNINGS YIELD AVG 5Y
N/A
EARNINGS YIELD AVG 10Y
N/A
EARNINGS YIELD AVG 15Y
N/A
EARNINGS YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
BioCryst Pharmaceuticals, Inc.
Market Cap
$2.03B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.01B
Earnings Yield
6.65%
TTM Avg
6.22%
3Y Avg
3.42%
5Y Avg
3.42%
Market Cap
$2.00B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.00B
Earnings Yield
14.76%
TTM Avg
9.78%
3Y Avg
7.02%
5Y Avg
7.02%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioCryst Pharmaceuticals, Inc. (BCRX) | $2.03B | N/A | N/A | N/A | N/A |
| Azenta, Inc. (AZTA)vs › | $2.03B | N/A | 1.68% | 5.59% | 5.05% |
| AxoGen, Inc. (AXGN)vs › | $2.02B | N/A | 98.76% | 98.76% | 79.11% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.01B | 6.65% | 6.22% | 3.42% | 3.42% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.00B | N/A | N/A | N/A | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.00B | 14.76% | 9.78% | 7.02% | 7.02% |
| Alvotech (ALVO)vs › | $2.05B | N/A | 3.77% | 3.77% | 3.77% |
| Immunome, Inc. (IMNM)vs › | $1.98B | N/A | N/A | N/A | N/A |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.09B | N/A | N/A | N/A | N/A |
| Addus HomeCare Corporation (ADUS)vs › | $2.10B | 5.06% | 4.80% | 4.13% | 3.70% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS YIELD |
|---|---|
| 2026-05-06 | 13.58% |
| 2026-05-05 | 13.27% |
| 2026-05-04 | 13.03% |
| 2026-05-01 | 13.04% |
| 2026-04-30 | 13.09% |
| 2026-04-29 | 13.33% |
| 2026-04-28 | 13.53% |
| 2026-04-27 | 13.47% |
| 2026-04-24 | 13.41% |
| 2026-04-23 | 13.68% |
| 2026-04-22 | 13.30% |
| 2026-04-21 | 13.97% |
| 2026-04-20 | 13.04% |
| 2026-04-17 | 12.62% |
| 2026-04-16 | 12.59% |
| 2026-04-15 | 12.70% |
| 2026-04-14 | 12.40% |
| 2026-04-13 | 12.74% |
| 2026-04-10 | 12.54% |
| 2026-04-09 | 12.12% |
| 2026-04-08 | 12.26% |
| 2026-04-07 | 12.50% |
| 2026-04-06 | 12.66% |
| 2026-04-02 | 13.29% |
| 2026-04-01 | 12.78% |
| 2026-03-31 | 12.59% |
| 2026-03-30 | 12.68% |
| 2026-03-27 | 12.85% |
| 2026-03-26 | 12.54% |
| 2026-03-25 | 12.75% |
| 2026-03-24 | 12.41% |
| 2026-03-23 | 12.23% |
| 2026-03-20 | 12.36% |
| 2026-03-19 | 12.22% |
| 2026-03-18 | 13.09% |
| 2026-03-17 | 13.02% |
| 2026-03-16 | 12.89% |
| 2026-03-13 | 14.58% |
| 2026-03-12 | 14.30% |
| 2026-03-11 | 14.12% |
| 2026-03-10 | 13.70% |
| 2026-03-09 | 13.91% |
| 2026-03-06 | 14.14% |
| 2026-03-05 | 14.10% |
| 2026-03-04 | 13.99% |
| 2026-03-03 | 13.79% |
| 2026-03-02 | 13.89% |
| 2026-02-27 | 13.70% |
